|
|
ASH 2011: Dr. Lonial - A Phase 2 Study of Elotuzumab in Combination with Lenalidomide and Low-Dose Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma
Sagar Lonial, MD
Winship Cancer Institute
Emory University School of Medicine
Atlanta, Georgia, USA
|
|
|
button next to the volume control in the
lower right hand corner.
print
related articles